P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
- DOI
- 10.1097/01.hs9.0000848800.77383.3d
- Published
- 2022-06
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/01.hs9.0000848800.77383.3d,
title = {P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE},
author = {B. Andemariam and A. Inati and R. Colombatti and C. Minniti and C. Brown and M. Hottmann and S. Gray and C. Hoppe and M. Davis and P. Yue},
year = {2022},
journal = {HemaSphere},
doi = {10.1097/01.hs9.0000848800.77383.3d},
url = {https://doi.org/10.1097/01.hs9.0000848800.77383.3d}
}RIS
TY - JOUR TI - P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE AU - B. Andemariam AU - A. Inati AU - R. Colombatti AU - C. Minniti AU - C. Brown AU - M. Hottmann AU - S. Gray AU - C. Hoppe AU - M. Davis AU - P. Yue PY - 2022 JO - HemaSphere DO - 10.1097/01.hs9.0000848800.77383.3d UR - https://doi.org/10.1097/01.hs9.0000848800.77383.3d ER -
APA
Andemariam, B., Inati, A., Colombatti, R., Minniti, C., Brown, C., Hottmann, M., Gray, S., Hoppe, C., Davis, M., & Yue, P. (2022). P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE. HemaSphere. https://doi.org/10.1097/01.hs9.0000848800.77383.3d
Source records
- crossref · retrieved 2026-09-26T18:02:36.839Z